Dr. Reddy's intros generic SabrilThe Sabril brand and generic had a market value of approximately $141 million for the most recent 12 months ending in December 2020, according to IQVIA. Unichem gets FDA OK for generic CelebrexUnichem's generic Celebrex will be available in four dosage strengths: 50 mg, 100 mg, 200 mg, and 400 mg. Sandoz, Slayback Pharma partner to launch generic Firazyr Sandoz has signed a U.S. commercialization deal with Slayback Pharma to launch generic Firazyr (icatibant injection). Glenmark obtains FDA nod for generic Evekeo Evekeo tablets had a market value of approximately $21.5 million for the 12-month period ended November 2020, according to IQVIA. Unichem gets FDA nod for generic Zonegran Unichem's generic Zonegran provides a treatment for partial seizures in adult patients with epilepsy. Lupin gets FDA nod for generic Renvela Sevelamer carbonate tablets had a market value of approximately $348 million, according to IQVIA September 2020 data. Aurobindo gets FDA green light for generic Tobi Aurobindo’s generic tobramycin inhalation solution is used to treat cystic fibrosis in adults and pediatric patients age 6 years old and older with Pseudomonas aeruginosa. Strides Pharma obtains FDA clearance for generic Actigal Ursodiol capsules had a market value of approximately $45 million, according to IQVIA November data. Zydus Cadila obtains FDA OK for generic Cytomel Zydus Cadila’s generic Cytomel will be available in dosage strengths of 5 mcg, 25 mcg, and 50 mcg. Alembic gets FDA nod for generic ProAmatine Midodrine hydrochloride tablets have a market value of roughly $60 million for the 12 months ended September 2020, according to IQVIA. First Previous 134 135 136 137 138 Next Last
